Lamotrigine (Epilepsy) updated on 04-22-2025

Low birth weight (< 2500g)

R analysis
id Study   Lib. in paper Exposition period    Study type  Control type 
 
Tags OR 95%CI x1/n1 x0/n0 no cases no exposed ROB Ref.
S16017
R66490
Christensen (Lamotrigine) (Epilepsy), 2024 Low birth weight (<2500 g) during pregnancy (anytime or not specified) population based cohort retrospective unexposed, sick Adjustment: Yes 0.97 [0.83;1.13] 230/5,299   1,006/22,227 1,236 5,299
ref
S6394
R17470
Veiby (Controls unexposed, disease free) b, 2013 Low birth weight (< 2500 grams) during pregnancy (anytime or not specified) prospective cohort unexposed, disease free excluded Adjustment: Yes 1.20 [0.50;2.80]
excluded (control group)
6/103   5,024/106,899 5,030 103
ref
S6393
R17451
Veiby (Controls unexposed, sick) b, 2013 Low birth weight (< 2500 grams) during pregnancy (anytime or not specified) prospective cohort unexposed, sick Adjustment: No 1.43 [0.55;3.75] C 6/103   16/386 22 103
ref
Total 2 studies 0.98 [0.84;1.14] 1,258 5,402
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives

Forest plot

StudyTE95% CIn casesn exposedweightROBABCDEF Christensen (Lamotrigine) (Epilepsy), 2024Christensen, 2024 1 0.97[0.83; 1.13]1,2365,29998%ROB confusion: seriousROB selection: lowROB classification: criticalROB missing: lowROB mesure: moderateROB reporting: moderate Veiby (Controls unexposed, sick) b, 2013Veiby, 2013 2 1.43[0.55; 3.75]221032%ROB confusion: unclearROB selection: lowROB classification: lowROB missing: moderateROB mesure: moderateROB reporting: moderate Total (2 studies) I2 = 0% 0.98[0.84; 1.14]1,2585,4020.25.01.0ROB: A: confusion, B: selection, C: classification, D: missing, E: measurement, F: reportinglow,moderate,serious,critical,unclear,

1: Lamotrigine) (Epilepsy; 2: Controls unexposed, sick) ;

Sensitivity analysis

SubsetTE95% CIn casesn exposedkI2 Type of studies cohort studiescohort studies 0.98[0.84; 1.14]1,2585,4020%NAChristensen (Lamotrigine) (Epilepsy), 2024 Veiby (Controls unexposed, sick) b, 2013 2 case control studiescase control studies 0 Type of controls unexposed, sickunexposed, sick 0.98[0.84; 1.14]1,2585,4020%NAChristensen (Lamotrigine) (Epilepsy), 2024 Veiby (Controls unexposed, sick) b, 2013 2 Tags Adjustment   - No  - No 1.43[0.55; 3.75]22103 -NAVeiby (Controls unexposed, sick) b, 2013 1   - Yes  - Yes 0.97[0.83; 1.13]1,2365,299 -NAChristensen (Lamotrigine) (Epilepsy), 2024 1 All studiesAll studies 0.98[0.84; 1.14]1,2585,4020%NAChristensen (Lamotrigine) (Epilepsy), 2024 Veiby (Controls unexposed, sick) b, 2013 20.25.01.0

Publication bias and p-hacking diagnosis

funnel plot

Funnel plot not drawn. Less than 3 points.

Asymetry test p-value = NaN (by Egger's regression)

not enought points

p values plot

Funnel plot not drawn. Less than 3 points.

Sub-groups analysis using all included studies

excluded 6394

Sub-groupsTE95% CIn casesn exposedkI2ROB type of controls unexposed controls (disease free or unspecified)unexposed controls (disease free or unspecified) 1.20[0.51; 2.84]5,030103 -NAVeiby (Controls unexposed, disease free) b, 2013 1 unexposed, sick controlsunexposed, sick controls 0.98[0.84; 1.14]1,2585,4020%NAChristensen (Lamotrigine) (Epilepsy), 2024 Veiby (Controls unexposed, sick) b, 2013 20.510.01.0